Cresco Labs Announces Opening of 10th Pennsylvania Dispensary in Ambler

The opening expands the company’s Sunnyside brand in the state.

January 18, 2022

CHICAGO, Jan. 18, 2022 – PRESS RELEASE – Cresco Labs, a vertically integrated multistate operator and the No. 1 U.S. wholesaler of branded cannabis products, is expanding its Sunnyside brand in Pennsylvania with a new store located at 28 W. Skippack Pike in Ambler. This location becomes the company’s 10th store in Pennsylvania and 47th dispensary nationwide.

“We are thrilled to be opening our 10th store in Pennsylvania, a continuation of our strategy of going deeper in our footprint and tailoring to individual state dynamics,” Cresco Labs CEO and co-founder Charlie Bachtell said. “With our CPG and wholesale focus, we’ve been able to take the top market share in Pennsylvania according to Headset. Adding additional fully owned retail will support our brand building and provide more access to Cresco Labs’ amazing products for patients across Pennsylvania.”

Located in the borough of Ambler, north of Philadelphia, the dispensary is a few miles away from the Pennsylvania Turnpike, a superhighway transporting thousands of people daily east-west across the state. Sunnyside Ambler resides in an area home to large facilities operated by major pharmaceutical companies, including Johnson & Johnson, Merck and Janssen.

The dispensary will be open 9 a.m.-6 p.m. Monday through Thursday, and 9 a.m.-7 p.m. Friday and Saturday. Patients can place online orders, browsing live inventory, on www.Sunnyside.shop and pick up orders in-store the same day. Store phone is 267-405-2622.

For more information about Sunnyside, visit www.sunnyside.shop.